GGrantIndex
← Search

ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II:I. A RANDOMIZED BLINDED CONTROLLED TRIAL OF TH

$13,721,004N01FY2024AINIH

Leidos Biomedical Research, Inc., Frederick MD

Investigators

View original record on NIH RePORTER →